| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ce7f3e38103609841b75c287436bfb7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 |
| filingDate |
2021-05-10^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-10-05^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ff94af281b123794d7e8c6141405106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbc7e2b04534357148e8e8d6e25cbda6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_164222a6017d441d71ef8395beb1bfe9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_833092f09daee0313dd71b7ba379fd1c |
| publicationDate |
2021-10-05^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-11136320-B2 |
| titleOfInvention |
Fused ring derivative used as FGFR4 inhibitor |
| abstract |
A compound represented by formula I or a pharmaceutically acceptable salt thereof and a use thereof in preparing a drug for treating, stopping or preventing a disease or disorder mediated by FGFR4 activity. |
| priorityDate |
2018-07-27^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |